ACE and familial dilated cardiomyopathy: The prevalence of the use of angiotensin-converting-enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB) was significantly lower and the prevalence of the use of statin, and anti-platelet agents was significantly higher in the ICM group compared to the DCM group.